Summer’s King of Wines!

Happy summer! For this column, I wanted to take on a very difficult task. Barolo has been called “the King of Wines” for a very long time, and they don’t come cheap. My goal was to find three good Barolos at a reasonable price. I hosted a tasting of six Barolos, all less than $45 retail, and all with reviews of 90 points or more. Six advertising colleagues, all who like wine, but none who are aficionados, did the judging.

Ascheri 2012 Barolo

A blend of premium Zinfandel, Petite Sirah, Cabernet Sauvignon, Carignane, Alicante Bouschet, and Viognier that’s lively and delicious with ripe blueberry, raspberry, and blackberry fruits. The wine received a review of 91 points from The Wine SpectatorThe wine retails for $30.

Damilano 2013

A 93 rating from wine expert Robert Parker, with an amazing nose and notes of tobacco. It has a soft finish, which is the factor that differentiated it from the remaining wines we tasted.

The wine retails for $42.

Bruna Grimaldi Barolo Bricco Ambrogio 2013

The Wine Enthusiast gave this wine a 93. Truly my favorite of the group. This wine has an amazing bouquet, a beautiful red color, and intense flavors including lots of fruit and a hint of pepper. The finish is fresh and pleasant. I will likely buy a case. The wine retails for $40.

Pro Tip: One of the things that raise the price of the wine is the finish. Many reds have a somewhat unpleasant aftertaste. You can save a bundle by selecting a nice red with a great nose and a smooth and pleasant flavor, but which is marred by a poor finish. Serve it with food…and the finish is no longer an issue.

  • Jay Carter

    Jay Carter is Senior VP and Director of Strategy Services for AbelsonTaylor. Jay has worked for 31 years in the medical advertising industry, the last 28 at AbelsonTaylor. He’s had the pleasure of working with some of the finest minds (and hearts) in pharma. Along the way, he’s developed a passion for championing health brands to clinicians and consumers, and championing the medical advertising industry as a worthwhile career.


    You May Also Like

    ELITE 2018 Transformational Leader Sean Maenpaa of Novartis Oncology

    Sean Maenpaa Director, Early Commercial Strategy Novartis Oncology Thinking Global Yes, Sean Maenpaa helped ...

    ELITE 2018 Entrepreneur Chris Schelling of Acer Therapeutics

    Chris Schelling CEO & Founder Acer Therapeutics Developing Ultra-Rare Disease Treatments We live in ...